Silencing of ribonucleotide reductase subunit M1 potentiates the antitumor activity of gemcitabine in resistant cancer cells

Lignende værker

• Stearoyl gemcitabine nanoparticles overcome resistance related to the over-expression of ribonucleotide reductase subunit M1
  af: Chung, Woon-Gye, et al.
  Udgivet: (2011)
• In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles
  af: Sloat, Brian R., et al.
  Udgivet: (2011)
• Enhanced subunit interactions with gemcitabine-5′-diphosphate inhibit ribonucleotide reductases
  af: Wang, Jun, et al.
  Udgivet: (2007)
• Just Getting Into Cells is Not Enough: Mechanisms Underlying 4-(N)-Stearoyl Gemcitabine Solid Lipid Nanoparticle's Ability to Overcome Gemcitabine Resistance Caused by RRM1 Overexpression
  af: Wonganan, Piyanuch, et al.
  Udgivet: (2013)
• Structures of eukaryotic ribonucleotide reductase I define gemcitabine diphosphate binding and subunit assembly
  af: Xu, Hai, et al.
  Udgivet: (2006)